Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: No
Stroke 35:804-805,806, Tong,D.C. &Becker,K.J., 2004
Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: Yes
Stroke 35:803-804,806, Furlan,A.J., 2004
Patent Foramen Ovale Management for Secondary Stroke Prevention:State-of-the-Art Appraisal of Current Evidence
Stroke 55:236-247, Sposato,L.A.,et al, 2024
Patent Foramen Ovale and Cryptogenic Stroke in Older Patients
NEJM 357:2262-2268, Handke,M.,et al, 2007
Age As a Determinant of Adverse Events in Medically Treated Cryptogenic Stroke Patients with Patent Foramen Ovale
Stroke 35:2145, Homma,S.,et al, 2004
Association Between Age and Risk of Stroke or Death from Carotid Endarterectomy and Carotid Stenting: A Meta-Analysis of Pooled Patient Data from Four Randomised Trials
Lancet 387:1305-1311, Howard, G.,et al, 2016
Intracranial Atherosclerosis
Lancet 383:984-998, Qureshi, A. & Caplan, L.R., 2014
Operator Experience and Carotid Stenting Outcomes in Medicare Beneficiaries
JAMA 306:1338-1343,1378, Nallamothu, B.K.,et al, 2011
Short-Term Outcome After Stenting Versus Endarterectomy for Symptomatic Carotid Stenosis: A Preplanned Meta-Analysis of Individual Patient Data
Lancet 376:1062-1073, 1028, Amarenco,P.,et al, 2010
Invasive Treatment for Coronary Artery Disease in the Elderly
Arch Int Med 151:1085-1088, Gold,S.,et al, 1991
Large Virchow-Robin Spaces, MR-Clinical Correlation
AJNR 10:929-936, Heier,L.A.,et al, 1989